Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC).

Tarih
2020
Yazar
Antonia, Scott Joseph
Quantin, Xavier
Hui, Rina
Ozguroglu, Mustafa
Murakami, Shuji
Broadhurst, Helen
Newton, Michael
Dennis, Phillip A.
Naidoo, Jarushka
Vansteenkiste, Johan F.
Faivre-Finn, Corinne
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/38768
Koleksiyonlar